Back to Search Start Over

PB1862: BRUIN CLL-313: A PHASE 3 OPEN-LABEL, RANDOMIZED STUDY OF PIRTOBRUTINIB VS BENDAMUSTINE+RITUXIMAB IN UNTREATED PATIENTS WITH CHRONIC LYMPHOCYTIC LEUKEMIA/SMALL LYMPHOCYTIC LYMPHOMA (TRIAL IN PROGRESS)

Authors :
W. Jurczak
C. Dartigeas
M. Coscia
P. Ganly
G. Al-Jazayrly
C. Wang
K. Bao
C. C. Leow
S. Shahda
P. L. Zinzani
Source :
HemaSphere, Vol 6, Pp 1742-1743 (2022)
Publication Year :
2022
Publisher :
Wiley, 2022.

Details

Language :
English
ISSN :
25729241
Volume :
6
Database :
Directory of Open Access Journals
Journal :
HemaSphere
Publication Type :
Academic Journal
Accession number :
edsdoj.955721feeb4d4ca34c9908ae0e4665
Document Type :
article
Full Text :
https://doi.org/10.1097/01.HS9.0000850300.53785.f4